Efficacy and safety of QVA149 compared with salmeterol/fluticasone combination (SFC) in Chinese patients with moderate-to-severe COPD: A subgroup analysis from the LANTERN study

被引：0
|
作者：
Zhong, Nanshan [1 ]
Wang, Changzheng [2 ]
Zhou, Xiangdong [3 ]
Zhang, Nuofu [1 ]
Patalano, Francesco [4 ]
Humphries, Michael [5 ]
Wang, Linda [5 ]
Banerji, Donald [6 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[2] Third Mil Med Univ, Xin Qiao Hosp, Inst Resp Dis, Chongqing, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China
[4] Novartis Pharma AG, Resp, Basel, Switzerland
[5] Beijing Novartis Pharma Co Ltd, Resp, Beijing, Peoples R China
[6] Novartis Pharmaceut, Resp, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
COPD; -; manag; ement; Bronchodilators; Treatments;
D O I：
10.1183/13993003.congress-2015.PA990
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA990
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy And Safety Of Qva149 Compared With Salmeterol/fluticasone Combination In Chinese Patients With Moderate To Severe COPD: A Subgroup Analysis From The Lantern Study
    Zhong, N.
    Wang, C.
    Zhou, X.
    Zhang, N.
    Patalano, F.
    Humphries, M.
    Wang, L.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [2] EFFICACY AND SAFETY OF IND/GLY COMPARED WITH SALMETEROL/FLUTICASONE COMBINATION IN CHINESE PATIENTS WITH MODERATE-TO-SEVERE COPD: A SUBGROUP ANALYSIS FROM THE LANTERN STUDY
    Larbig, Michael
    Zhong, Nanshan
    Wang, Changzheng
    Zhou, Xiangdong
    Zhang, Nuofu
    Patalano, Francesco
    Humphries, Michael
    Wang, Linda
    Banerji, Donald
    RESPIROLOGY, 2015, 20 : 45 - 45
  • [3] EVALUATION OF EFFICACY AND SAFETY OF SWITCHING TO QVA149 FROM SALMETEROL/FLUTICASONE IN SYMPTOMATIC PATIENTS WITH MODERATE-TO-SEVERE COPD: THE FLASH STUDY
    Frith, Peter
    Riachy, Moussa
    Ditommaso, Shelley
    Fogel, Robert
    Pilipovic, Virginia
    RESPIROLOGY, 2015, 20 : 39 - 39
  • [4] LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
    Zhong, Nanshan
    Wang, Changzheng
    Zhou, Xiangdong
    Zhang, Nuofu
    Humphries, Michael
    Wang, Linda
    Thach, Chau
    Patalano, Francesco
    Banerji, Donald
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1015 - 1026
  • [5] Qva149 Significantly Lowers The Rate And Risk Of Moderate Or Severe COPD Exacerbation Versus Salmeterol/fluticasone In Patients With Moderate To Severe COPD: The Lantern Study
    Zhong, N.
    Wang, C.
    Zhou, X.
    Zhang, N.
    Patalano, F.
    Humphries, M.
    Wang, L.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] QVA149 compared with salmeterol/fluticasone (SFC) on exacerbations and its correlation with baseline blood eosinophils: A pooled analysis of LANTERN and ILLUMINATE
    Wedzicha, Jadwiga A.
    Price, David
    Mezzi, Karen
    Fogel, Robert
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In A Subgroup Of Patients With Severe COPD: The Spark Study
    Wedzicha, J.
    D'Urzo, A. D.
    Decramer, M.
    Ficker, J. H.
    Sandstrom, T.
    Taylor, A. Fowler
    D'Andrea, P.
    Mezzi, K.
    Chen, H.
    Banerji, D.
    Fogel, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] QVA149 is more efficacious than tiotropium and salmeterol/fluticasone combination (SFC) in improving patient-reported outcomes and lung function in COPD patients with moderate-to-severe baseline dyspnoea: The IGNITE trials
    Mahler, Donald
    Keininger, Dorothy
    Fogel, Robert
    Mezzi, Karen
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [9] CARDIO- AND CEREBROVASCULAR SAFETY OF QVA149 IN PATIENTS WITH MODERATE TO SEVERE COPD: A POOLED ANALYSIS
    Frith, P.
    Dahl, R.
    Buhl, R.
    Mezzi, K.
    Schubert-Tennigkeit, A.
    Chen, H.
    Banerji, D.
    Fogel, R.
    RESPIROLOGY, 2015, 20 : 81 - 81
  • [10] DUAL BRONCHODILATION WITH QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: IGNITE TRIALS OVERVIEW
    Mezzi, Karen
    Fedele, Mark J.
    Chen, Hungta
    Banerji, Donald
    RESPIROLOGY, 2013, 18 : 69 - 69
12345